Literature DB >> 19409383

Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression.

Frank Padberg1, Mark S George.   

Abstract

Transcranial magnetic stimulation is an interesting technique for non-invasively stimulating the brain in awake alert humans. It is a powerful research tool for examining brain behavior relationships. Additionally many researchers are investigating whether repeatedly applying TMS to specific regions over several days to weeks might have therapeutic effects. By far the largest amount of work has been done investigating whether daily applications of prefrontal TMS can improve the symptoms of major depression. We review the literature combining TMS with brain imaging, and then overview the clinical work done to date with TMS in depression. The literature to date suggests that daily prefrontal TMS for several weeks clearly has antidepressant effects, but much work remains to establish the effect sizes and improve the methods of delivery in order to improve its potential clinical utility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409383     DOI: 10.1016/j.expneurol.2009.04.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  60 in total

1.  Model-driven therapeutic treatment of neurological disorders: reshaping brain rhythms with neuromodulation.

Authors:  Julien Modolo; Alexandre Legros; Alex W Thomas; Anne Beuter
Journal:  Interface Focus       Date:  2010-11-17       Impact factor: 3.906

Review 2.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

3.  Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study.

Authors:  Xingbao Li; Robert J Malcolm; Kristina Huebner; Colleen A Hanlon; Joseph J Taylor; Kathleen T Brady; Mark S George; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

4.  Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

Authors:  Michael D Fox; Randy L Buckner; Hesheng Liu; M Mallar Chakravarty; Andres M Lozano; Alvaro Pascual-Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 5.  A perfect match: noninvasive brain stimulation and psychotherapy.

Authors:  Malek Bajbouj; Frank Padberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-25       Impact factor: 5.270

6.  Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.

Authors:  Anne Weigand; Andreas Horn; Ruth Caballero; Danielle Cooke; Adam P Stern; Stephan F Taylor; Daniel Press; Alvaro Pascual-Leone; Michael D Fox
Journal:  Biol Psychiatry       Date:  2017-11-10       Impact factor: 13.382

7.  Subclinical depression severity is associated with distinct patterns of functional connectivity for subregions of anterior cingulate cortex.

Authors:  Carissa L Philippi; Julian C Motzkin; Maia S Pujara; Michael Koenigs
Journal:  J Psychiatr Res       Date:  2015-10-09       Impact factor: 4.791

8.  Enhancing plasticity through repeated rTMS sessions: the benefits of a night of sleep.

Authors:  Daniel A Cohen; Catarina Freitas; Jose Maria Tormos; Lindsay Oberman; Mark Eldaief; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2010-06-11       Impact factor: 3.708

9.  [Transcranial and invasive brain stimulation for depression].

Authors:  C Plewnia; F Padberg
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 10.  Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.

Authors:  Pablo Andrade; Lieke H M Noblesse; Yasin Temel; Linda Ackermans; Lee W Lim; Harry W M Steinbusch; Veerle Visser-Vandewalle
Journal:  Acta Neurochir (Wien)       Date:  2010-01-26       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.